What is the most recent earnings date for KZIA stock?
KAZIA THERAPEUTICS-SPON ADR (KZIA) last reported earnings on 11/7/2025.
NASDAQ:KZIA • US48669G3039
Past quarterly earnings results for KAZIA THERAPEUTICS-SPON ADR (KZIA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in AUD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.42 | -1.33 | 207.09% | - | 42K | 8.16K | 414.71% | -98.18% |
| Q2 2025 | -12.30 | -17.44 | 29.48% | - | 28.7K | - | -100.00% | |
| Q4 2024 | - | - | 2.314M | - | - | |||
| Q2 2024 | - | - | 6.5K | - | 6,400.00% | |||
| Q4 2023 | -9.50 | -2.55 | -272.55% | 78.19% | 22.4K | 23.46K | -100.00% | -100.00% |
| Q2 2023 | - | - | 100 | - | -95.00% | |||
| Q4 2022 | -43.55 | -5.10 | -753.92% | - | 100 | 518.16K | -99.98% | -100.00% |
| Q2 2022 | - | - | 2K | - | -93.51% | |||
| Q4 2021 | - | - | 15.194M | - | 45,527.93% | |||
| Q2 2021 | -29.50 | -3.06 | -864.05% | -23,080.89% | 30.8K | 612K | -94.97% | -5.52% |
| Q4 2020 | - | - | 33.3K | - | - | |||
| Q2 2020 | -0.13 | - | - | 32.6K | 1.522M | -97.86% | - |
Notes
KAZIA THERAPEUTICS-SPON ADR (KZIA) last reported earnings on 11/7/2025.
KAZIA THERAPEUTICS-SPON ADR (KZIA) beat EPS estimates and beat revenue estimates in the most recent quarter.